Correlation of the density of yeast Malassezia with the clinical severity of seborrhoeic dermatitis

Journal of the Pakistan Medical Association

Volumn 52, Issue 11, 2002, Pages 504-506

  Zaidi, Z ^a   Wahid, Z ^a   Cochinwala, R ^b   Soomro, M ^b   Qureishi, A ^b  

^a CIVIL HOSPITAL   (Pakistan)

^b Institute of Skin Diseases   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DERMATITIS; DISEASE SEVERITY; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALASSEZIA; MALE; NONHUMAN; SEBORRHEIC DERMATITIS; YEAST;

ADOLESCENT; ADULT; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; FEMALE; HUMANS; MALASSEZIA; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0036875069     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Parry EM, Sharpe RG. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br. J. Dermatol., 1998; 139: 254-63.
2. Skimmer BR, Noah WP, Taylor MR, et al. Double blind treatment of seborrhoeic dermatitis with 2% ketokonazole cream. J. Am. Acad. Dermatol., 1985; 12: 852-56.
3. Carr MM, Pyrce MD, Ive AF. Treatment of seborrhoeic dermatitis with ketokonazole: 1. Response of seborrhoeic dermatitis of the scalp to topical ketokonazole. Br. J. Dermatol., 1987; 116: 213-16.
4. Green AC, Farr M.P Shuster S. Treatment of seborrhoeic dermatitis with ketokonazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketokonazole. Br. J. Dermatol., 1987; 116: 217-21.
5. Shuster S. The etiology of dandruff and the mode of action of therapeutic agents. Br J of Dermatol. 1984; 111: 235-242.
6. McGinley JK, Leyden JJ, Marples RR, et al. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J. Invest. Dermatol., 1975; 64: 401-5.
7. Heng YCM, Henderson LC, Barker CD, et al. Correlation of Pityrosporum density with the clinical severity of seborrhoeic dermatitis as assessed by a simplified technique. J. Am. Acad. Dermatol., 1990; 23: 82-86.
8. Grossier D, Button JE, Lebwohl M. Association of Pityrospomm orbiculare (Malassezia furfur) with seborrhoeic dermatitis on patients with acquired immunodeficiency syndrome (AIDS). J. Am. Acad. Dermatol., 1989; 20: 770-73.
9. Roia FC, Vanderwyk RW. Resident microflora of the human scalp and its relationship to dandruff. J. Soc. Cosmec. Chem., 1969; 20: 113-34.
10. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology, 1998; 196: 140-47.
11. Burton LJ, Holden AC. Eczema Lichenification and Prurigo In: Rook A., Wilkinson DS, Ebling FJG, Champion RH, Burton LJ Textbook of Dermatology. 6th Edition. Blackwell Scientific Publication. 1998, pp. 638-43.
12. Pirkhammer D, Seeber A, Honigsmann HH, et al. Narrow band (TL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br. J Dermatol., 2000; 143: 964-68.
13. Nakayama J. Four cases of sebopsoriasis or seborrhoeic dermatitis of the face and scalp successfully treated with 1a-24 (R) dehydroxycholecalciferol. (tacalcitol) cream. Euro. J. Dermatol., 2000; 10: 528-32.
14. Baroni A, Rossa R. New strategies in dandruff treatment: growth control of Pityrosporum ovalis. Dermatology, 2000; 201: 332-36.
15. Prasad D, Pandhi R, Negi SK, et al. Topical metronidazole in seborrhoeic dermatitis - a double blind study. Dermatology, 2001; 202: 35-37.